PPT-Anticoagulation in Atrial

Fibrillation Michelle Tsukamoto DSR 2 May 9 2018 PGY 2 1 Objectives Discuss which patients with atrial fibrillation should be anticoagulated for CVA prevention Learn about different oral anticoagulation options . fibrillation: diagnosis and management. د. حسين محمد جمعة . اختصاصي الامراض الباطنة . البورد العربي . كلية طب الموصل . 2010. Journal Club . October 21,2015. Kathleen McNamara, . PharmD. Stroke Risk Calculation. Which tool do you most typically use to evaluate stroke . risk for patients with a fib? . CHADS2 score. CHADS2-VASc. . . Feb 08/2014. Hanadi. . Alhozali,MBBS,ABIM,FRCPC. Assistant professor consultant internal medicine and Nephrology KAUH/Jeddah. Glomerular- based disease and Renal disease in pregnancy. Objectives. . . Feb 08/2014. Hanadi. . Alhozali,MBBS,ABIM,FRCPC. Assistant professor consultant internal medicine and Nephrology KAUH/Jeddah. Glomerular- based disease and Renal disease in pregnancy. Objectives. Martha Drake MS, FNP-BC. Chicago Heart and Vascular Consultants, LTD. Purdue Northwest Doctorate of Nursing Program. Learning Objectives. Discuss the incidence of atrial fibrillation (AF) in the population. A . CASE SERIES AND REVIEW OF THE LITERATURE . 1. Lily . K. . Fatula. , BS; . 1,2. William . D. Bolton, MD; . 1,2. Barry . R. Davis, MD; . 1,2. James . E. Stephenson, MD; . 1,2. Sharon . Ben-Or, MD. . Mary N. Healy, MS, ARNP-BC. Heart & Vascular Center of Sarasota. OBJECTIVES. Define the difference between paroxysmal and persistent Atrial Fibrillation. State the CVA risk per year of a 68 . yr. Jennie Hsu-. Lumetta. , MD, FACP. Corinne Kohler, . MD, FAAFP. Narain. . Mandhan. , MD, FACP, FASAM. Karen . Wiarda. , . DO. Muhammad . Ajmal. , . MD, PGY 3 Chief. ACP QI . Project. Atrial Fibrillation . Overview . Definition and epidemiology. Symptoms. Tests/Evaluations. Complications. Treatment. Effects on exercise. Medications effect on exercise. Effects of training. Exercise prescription. Definition. <1% of individuals aged 60 to 65 years . 8% to 10% of individuals aged >80 years . Men more than women . White persons more than black persons. Presence and severity of underlying heart disease increases risk . Figure 1 ). Management TheappropriatemanagementofAFisdependentupontheclinicalcontextinwhichitisencountered.Themajorityofcasescanbedealtwithappropriatelyonanoutpatientbasis.TheapproachtothetreatmentofA Guidelines for Clinical Care Inpatient Atrial Fibrillation Guideline TeamTeam MembersJeffrey M Rohde(Team Lead)Internal MedicineSarah E Hartley, MDInternal MedicineSarah Hanigan, PharmDPharmacy Servic  . Joshua P. Rainey. 1,3. , Olivia R. Palmer. 2. , Cathy Luke. 3. , José A. Diaz. 3. .  . 1. University of Michigan Medical School; . 2. Department of Biomedical Engineering, University of Michigan, Ann Arbor, MI; . - The NOAH-AFNET 6 trial -. Nina Becher, Tobias Toennis, Emanuele Bertaglia, Carina Blomstrom-Lundqvist, Nuno Cabanelas, Melanie Calvert, A John Camm, Gregory Chlouverakis, Gheorghe-Andrei Dan, Wolfgang Dichtl, Hans Christoph Diener, Alexander...